Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 3Terminated 2Recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Gastrointestinal 1

Conditions

Mycosis Fungoides 2Sezary Syndrome 1Lymphoma 1

Interventions

Rituximab 227Cyclophosphamide 142fludarabine 69Vincristine 66Methotrexate 62Doxorubicin 54fludarabine phosphate 53Lenalidomide 49Etoposide 49Cytarabine 48Prednisone 47Dexamethasone 44Filgrastim 43Bortezomib 38Whole-Body Irradiation 34Gemcitabine 34Melphalan 32Radiotherapy 30ibrutinib 29Granulocyte Colony-Stimulating Factor 29Alemtuzumab 29obinutuzumab 28Tacrolimus 28Mycophenolic Acid 28Antilymphocyte Serum 28venetoclax 27Calcium Dobesilate 27Busulfan 27Bendamustine Hydrochloride 27idelalisib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Methoxsalen × Lymphoid × Clear all
NCT00056056 2018-07-09

Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
93 enrolled
Lymphoid

Lymphoma, Mycosis Fungoides, Sezary Syndrome

NCT00630903 2008-03-07

MF99

Madrilenian Group of Cutaneous Lymphomas

Phase 4 Terminated
54 enrolled
Lymphoid

Mycosis Fungoides

Data powered by HemOnc (CC BY 4.0) Colophon âš¡